Microvast Holdings announces departure of chief financial officer
CALGARY, May 1, 2025 – SNDL Inc., formerly known as Sundial Growers Inc (NASDAQ:SNDL)., has submitted a Form 6-K with the United States Securities and Exchange Commission (SEC) for the month of May 2025. The document, filed today, indicates that SNDL Inc. will continue to file annual reports under Form 40-F, which is used by certain Canadian issuers under the multi-jurisdictional disclosure system.
The SEC filing was signed by SNDL Inc.’s Chief Financial Officer, Alberto Paredero Quiros, confirming the company’s compliance with the requirements of the Securities Exchange Act of 1934. The filing includes a news release dated May 1, 2025, as an exhibit, which provides additional information regarding SNDL Inc.’s recent activities and developments.
SNDL Inc., operating under the name 03 Life Sciences, is a company incorporated in the medicinal chemicals and botanical products industry, as per the standard industrial classification. The company’s business address is located at 919 11 Avenue SW, Suite 300, Calgary, with a mailing address matching the business address.
This SEC filing provides investors and the public with the latest regulatory information concerning SNDL Inc. The company has ensured that all necessary legal requirements have been met in the process of this filing.
Investors interested in SNDL Inc.’s financial and corporate affairs can refer to this latest Form 6-K filing for detailed information. The document is based on a press release statement and is intended to keep shareholders and the market informed of the company’s compliance and reporting practices as per SEC regulations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.